Skip to main content
Science / Explained
Reading What Actually MattersArticle 2 of 5

What Purity Percentages Actually Mean

A purity percentage is not a ranking. It is a result produced under a specific method, from a specific sample, under specific conditions. The number is only meaningful inside the full documentation picture.

Purity is usually the number people notice first.

It is easy to understand why. A percentage feels simple. It gives the reader something concrete to hold onto. A higher number appears stronger. A lower number appears weaker. The number seems to offer a quick answer.

But purity is not that simple.

A purity percentage is not a complete description of quality. It is a result produced under a specific analytical method, using a specific sample, under specific testing conditions. It tells the reader something important, but not everything.

THE NUMBER

When a COA reports purity, it is usually describing how much of the detected sample corresponds to the intended compound under the method used. In peptide testing, purity and related impurities are important quality attributes because synthetic peptide production can generate closely related impurities, fragments, or byproducts that need to be separated, detected, and understood. (Polypeptide)

That is why purity matters.

But the number should not be read alone.

A purity result becomes meaningful when the reader also knows what method was used, whether identity was confirmed, whether the test is batch-specific, and whether the report provides enough context to interpret the result. Without that context, the number can create a false sense of clarity.

A high number can look reassuring.

But the real question is how that number was generated.

THE METHOD

Different analytical procedures can produce different kinds of information.

A method used to assess purity is not the same as a method used to confirm identity. A method used to detect one class of impurity may not tell the reader everything about every possible impurity. This is why method validation matters in regulated quality systems. ICH Q2(R2) explains that analytical procedure validation is meant to demonstrate that a procedure is fit for its intended purpose. (U.S. Food and Drug Administration)

That phrase matters: intended purpose.

It means a test must be understood according to what it is designed to measure. A purity number does not automatically answer questions outside the scope of that test. It should be read as one result inside a larger documentation picture.

WHY PURITY IS MISUNDERSTOOD

Purity is misunderstood because people want it to work like a ranking.

One number above another. One source better than another. One decision made simple.

But in peptides, purity is part of a larger quality conversation. The number may reflect synthesis quality, purification discipline, impurity control, analytical method, sample handling, and reporting structure. It is important, but it is not independent from everything that came before it.

This is why two purity numbers that look close may not be equally informative.

One may come with clear identity confirmation, batch traceability, method details, and a complete report. Another may appear as a single percentage without enough context to understand how it was produced.

The number may look similar.

The documentation may not be.

What this means

Purity should be read as a signal, not as the entire answer.

The better question is not only: what is the percentage?

The better question is: what does this percentage represent, how was it measured, and what other documentation supports it?

A purity number can be useful.

But only when it sits inside a clear structure of identity, method, batch connection, and traceability.

Catalyst reports purity inside that structure: identity, method, and batch alongside the number, not the number alone.

The better question is not what the percentage is. It is how that percentage was produced.

Previous
How to Read a COA Without a Science Background
Next
What Third-Party Testing Verifies, and What It Doesn't
Related articles

How to Read a COA Without a Science Background

A Certificate of Analysis is not a document written for experts. It is a structured record meant to connect a compound, a batch, a test method, and a result into one traceable story.

Read more

What Third-Party Testing Verifies, and What It Doesn't

Third-party testing is one of the strongest parts of a trust system when used correctly. It verifies what was tested, in the sample provided, using the method applied. It does not verify the entire supply chain.

Read more

Does a certificate of analysis prove a peptide is trustworthy?

A certificate of analysis is necessary, not sufficient.

Read more

Batch-Level Traceability Explained

Consistency is easy to claim. Batch-level traceability is how it is demonstrated. When documentation connects product, batch, and results into one path, the reader can follow it instead of assuming it.

Read more

Semaglutide Explained: How was semaglutide engineered to last 94% longer?

Semaglutide explained in one line: the molecule keeps most of native GLP-1's receptor-recognized shape, then adds targeted edits that extend duration from minutes to about a week.

Read more
Keep building trust

Move from the science to the proof, source, and practical questions.

Science next

How to Read a COA Without a Science Background

Keep the explanation moving with the next evidence-led Science article.

Keep learning

Science next

What Third-Party Testing Verifies, and What It Doesn't

Keep the explanation moving with the next evidence-led Science article.

Keep learning

Science next

Batch-Level Traceability Explained

Keep the explanation moving with the next evidence-led Science article.

Keep learning

Source standards

Our commitment

See how Catalyst frames sourcing, documentation, testing, and transparency.

Review the commitment

Product context

GLP-3 product page

Move from mechanism and evidence to the GLP-3 product context.

See GLP-3 context

Science next

What Are Peptides? Your Body Runs on 7,000 Peptide Signals

Keep the explanation moving with the next evidence-led Science article.

Keep learning
References6 sources
  1. United States Pharmacopeia (USP) · 2023
    Reference Standards to Support Quality of Synthetic Peptide Therapeutics.
    PMC / United States Pharmacopeia
  2. U.S. Food and Drug Administration · 2021
    ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin: Guidance for Industry.
    U.S. Food and Drug Administration
  3. ICH · 2000
    Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
    database.ich.org
  4. U.S. Food and Drug Administration · 2023
    Q2(R2) Validation of Analytical Procedures.
    U.S. Food and Drug Administration
  5. U.S. Food and Drug Administration · 2018
    Data Integrity and Compliance With Drug CGMP: Guidance for Industry.
    U.S. Food and Drug Administration
  6. PolyPeptide · 2014
    Control Strategies for Synthetic Therapeutic Peptide APIs, Part I: Analytical Consideration.
    Polypeptide

Disclaimer. This article is for educational purposes only and does not constitute medical advice. Peptide signals and their therapeutic applications are complex and context-dependent.